神経血管デバイス市場規模、シェア、動向分析レポート：デバイス別、治療用途別、規模別、最終用途別、地域別、セグメント別予測、2025年～2030年

神経血管デバイス市場の成長と動向

Grand View Research, Inc.の最新レポートによると、世界の神経血管デバイス市場規模は、2025～2030年にかけてCAGR 6.01％を記録し、2030年には45億3,000万米ドルに達する見込みです。

脳卒中、脳動脈瘤、脳動脈狭窄症などの神経疾患の有病率の上昇が神経血管機器市場の成長を促進しています。世界脳卒中機関（WSO）によると、2022年には年間1,220万人以上の脳卒中が新たに発生します。

25歳以上の成人の4人に1人が、生涯を通じて脳卒中に苦しむことになります。また、虚血性脳卒中は毎年約760万人が新たに発症します。世界中で発症する脳卒中の約62.0％は虚血性脳卒中であり、毎年120万件以上のくも膜下出血が新たに発症しています。その結果、神経血管デバイスに対する大きな需要があり、神経血管デバイス市場拡大の原動力となっていることが数字で示されています。

先進国と新興国の両方で脳動脈瘤の有病率が上昇していることが、技術的に先進的製品を市場に導入する原動力となっています。頭蓋内動脈瘤の重要な治療技術には、外科的クリッピング、血管内コイリング、フロー・ダイバータなどがあります。市場参入企業は、常に技術的に先進的な製品を市場に投入するよう努めています。

例えば、2021年9月、Medtronic plc.は、Rist 079 Access Radial Guide CatheterとAccess Rist Radial Selective Catheterからなる橈骨動脈アクセスポートフォリオのCEマーク認可を発表しました。さらに2022年3月、Micro Port Scientific Companyは、ハイパーフレックスバルーンカテーテルが独立行政法人医薬品医療機器総合機構（PMDA）から登録承認を取得したと発表しました。

術後の不快感の軽減と回復の早さは、低侵襲手術の利用を拡大し、このセグメントの研究開発に拍車をかけている要因です。血管内コイリングは低侵襲手術の一つで、脳動脈瘤の治療に臨床医から頻繁に提案されています。ハイドロコイル（MicroVention、米国カリフォルニア州タスティン）は、ベアプラチナコイルと比較して再発率が低く、より複雑な動脈瘤構造の治療を可能にしました。その結果、低侵襲治療に対する需要の増加が神経血管デバイス市場の拡大を支えています。

神経血管デバイス市場レポートハイライト

• 脳塞栓・動脈瘤コイリングデバイスは、2024年に約36.02%の最大市場シェアを占めました。コイル塞栓術は動脈瘤治療のための低侵襲手技であり、材料が嚢を閉鎖して出血のリスクを低減します。
• 脳卒中は、高血圧、脳卒中、その他の神経疾患の有病率の増加などの要因により、2024年に約56.86％の最大市場シェアを占めました。
• 0.021インチは2024年に約27.08％の最大市場シェアを占めました。このセグメントの成長は、0.021インチデバイスが提供するさまざまな利点と、さまざまな製品の発売や製品承認に起因しています。
• 病院は2024年に約70.79％の最大市場シェアを占めました。このセグメントの成長は、虚血性・出血性脳卒中、脳動脈瘤、外傷性脳損傷（TBI）、動静脈奇形（AVM）などの神経血管障害を患う患者が増加していることが主因と考えられます。
• 北米の神経血管デバイスは、Penumbra, Inc.、Stryker Corporation、Johnson & Johnson、Merit medical systems, Inc.などの主要メーカーの存在により、2024年には27.62%のシェアで市場を独占しました。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 神経血管デバイスの変数、動向、範囲

• 市場系統の展望
  • 親市場の展望
  • 関連/付随市場の展望
• 市場力学
  • 市場促進要因分析
  • 市場抑制要因分析
• 神経血管デバイス分析ツール
  • 産業分析-ポーターのファイブフォース分析
  • PESTEL分析

第4章 神経血管デバイス市場： セグメント分析、デバイス別、2018～2030年（100万米ドルと数量単位）

• 定義と範囲
• デバイス市場シェア分析、2024年と2030年
• 世界の神経血管デバイス市場、デバイス別、2018～2030年
• 市場規模と予測と動向分析、2018～2030年

第5章 神経血管デバイス市場： セグメント分析、治療用途別、2018～2030年（100万米ドル）

• 定義と範囲
• 治療用途市場シェア分析、2024年と2030年
• 世界の神経血管デバイス市場、治療用途別、2018～2030年
• 市場規模と予測と動向分析、2018～2030年

第6章 神経血管デバイス市場：セグメント分析、規模別、2018～2030年（100万米ドル）

• 定義と範囲
• 規模市場シェア分析、2024年と2030年
• 世界の神経血管デバイス市場、規模別、2018～2030年
• 市場規模と予測と動向分析、2018～2030年

第7章 神経血管デバイス市場： セグメント分析、最終用途別、2018～2030年（100万米ドル）

• 定義と範囲
• 最終用途市場シェア分析、2024年と2030年
• 世界の神経血管デバイス市場、最終用途別、2018～2030年
• 市場規模と予測と動向分析、2018～2030年

第8章 神経血管デバイス市場：地域別、推定・動向分析

• 地域ダッシュボード
• 市場規模、予測動向分析、2018～2030年
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • ノルウェー
  • スウェーデン
  • デンマーク
• アジア太平洋
  • 日本
  • 中国
  • インド
  • オーストラリア
  • 韓国
  • タイ
• ラテンアメリカ
  • ブラジル
  • アルゼンチン
  • メキシコ
• 中東・アフリカ
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第9章 競合情勢

• 市場参入企業の分類
• 主要市場参入企業による最近の動向と影響分析
• 企業市場シェア分析、2024年
• 主要企業プロファイル
  • Medtronic
  • Stryker Corporation
  • Terumo Corporation
  • Penumbra, Inc.
  • Johnson & Johnson Services, Inc.
  • Integra LifeSciences Corporation
  • Acandis GmbH
  • Spiegelberg GmbH &Co. KG
  • MicroPort Scientific Corporation
  • ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.

List of Tables

• Table 1. List of secondary sources
• Table 2. List of abbreviation
• Table 3. North America neurovascular devices market, by country, 2018 - 2030 (USD Million)
• Table 4. North America neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 5. North America neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 6. North America neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 7. North America neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 8. U.S. neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 9. U.S. neurovascular devices, by therapeutic application, 2018 - 2030 (USD Million)
• Table 10. U.S. neurovascular devices, by size, 2018 - 2030 (USD Million)
• Table 11. U.S. neurovascular devices, by end use, 2018 - 2030 (USD Million)
• Table 12. Canada neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 13. Canada neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 14. Canada neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 15. Canada neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 16. Europe neurovascular devices market, by country, 2018 - 2030 (USD Million)
• Table 17. Europe neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 18. Europe neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 19. Europe neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 20. Europe neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 21. UK neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 22. UK neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 23. UK neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 24. UK neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 25. Germany neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 26. Germany neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 27. Germany neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 28. Germany neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 29. France neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 30. France neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 31. France neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 32. France neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 33. Italy neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 34. Italy neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 35. Italy neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 36. Italy neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 37. Spain neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 38. Spain neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 39. Spain neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 40. Spain neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 41. Norway neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 42. Norway neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 43. Norway neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 44. Norway neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 45. Sweden neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 46. Sweden neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 47. Sweden neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 48. Sweden neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 49. Denmark neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 50. Denmark neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 51. Denmark neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 52. Denmark neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 53. Asia Pacific neurovascular devices market, by country, 2018 - 2030 (USD Million)
• Table 54. Asia Pacific neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 55. Asia Pacific neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 56. Asia Pacific neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 57. Asia Pacific neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 58. China neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 59. China neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 60. China neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 61. China neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 62. Japan neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 63. Japan neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 64. Japan neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 65. Japan neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 66. India neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 67. India neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 68. India neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 69. India neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 70. Australia neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 71. Australia neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 72. Australia neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 73. Australia neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 74. South Korea neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 75. South Korea neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 76. South Korea neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 77. South Korea neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 78. Latin America neurovascular devices market, by country, 2018 - 2030 (USD Million)
• Table 79. Latin America neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 80. Latin America neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 81. Latin America neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 82. Latin America neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 83. Brazil neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 84. Brazil neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 85. Brazil neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 86. Brazil neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 87. Mexico neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 88. Mexico neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 89. Mexico neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 90. Mexico neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 91. Argentina neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 92. Argentina neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 93. Argentina neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 94. Argentina neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 95. Middle East & Africa neurovascular devices market, by country, 2018 - 2030 (USD Million)
• Table 96. Middle East & Africa neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 97. Middle East & Africa neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 98. Middle East & Africa neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 99. Middle East & Africa neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 100. South Africa neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 101. South Africa neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 102. South Africa neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 103. South Africa neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 104. Saudi Arabia neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 105. Saudi Arabia neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 106. Saudi Arabia neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 107. Saudi Arabia neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 108. UAE neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 109. UAE neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 110. UAE neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 111. UAE neurovascular devices market, by end use, 2018 - 2030 (USD Million)
• Table 112. Kuwait neurovascular devices market, by device, 2018 - 2030 (USD Million)
• Table 113. Kuwait neurovascular devices market, by therapeutic application, 2018 - 2030 (USD Million)
• Table 114. Kuwait neurovascular devices market, by size, 2018 - 2030 (USD Million)
• Table 115. Kuwait neurovascular devices market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig 1. Neurovascular devices market segmentation
• Fig 2. Market research process
• Fig 3. Information procurement
• Fig 4. Primary research pattern
• Fig 5. Market research approaches
• Fig 6. Value-chain-based sizing & forecasting
• Fig 7. QFD modeling for market share assessment
• Fig 8. Market formulation & validation
• Fig 9. Market outlook (2024)
• Fig 10. Segment Outlook
• Fig 11. Strategy framework
• Fig 12. Penetration & growth prospect mapping
• Fig 13. Market driver relevance analysis (Current & future impact)
• Fig 14. Market restraint relevance analysis (Current & future impact)
• Fig 15. Porter's five forces analysis
• Fig 16. SWOT analysis, by factor (political & legal, economic and technological)
• Fig 17. Neurovascular devices market: Device movement analysis
• Fig 18. Neurovascular devices market device outlook: Key takeaways
• Fig 19. Cerebral embolization and aneurysm coiling devices market, 2018 - 2030 (USD Million)
• Fig 20. Embolic coils market, 2018 - 2030 (USD Million)
• Fig 21. Flow diverters market, 2018 - 2030 (USD Million)
• Fig 22. Liquid embolic agents market, 2018 - 2030 (USD Million)
• Fig 23. Cerebral angioplasty and stenting systems market, 2018 - 2030 (USD Million)
• Fig 24. Carotid artery stents market, 2018 - 2030 (USD Million)
• Fig 25. Embolic protection systems devices market, 2018 - 2030 (USD Million)
• Fig 26. Neurothrombectomy devices market, 2018 - 2030 (USD Million)
• Fig 27. Clot retrieval devices market, 2018 - 2030 (USD Million)
• Fig 28. Suction devices market, 2018 - 2030 (USD Million)
• Fig 29. Vascular snares market, 2018 - 2030 (USD Million)
• Fig 30. Support devices market, 2018 - 2030 (USD Million)
• Fig 31. Micro catheters market, 2018 - 2030 (USD Million)
• Fig 32. Guidewires market, 2018 - 2030 (USD Million)
• Fig 33. Trans radial access devices market, 2018 - 2030 (USD Million)
• Fig 34. Neurovascular devices market: Therapeutic application movement analysis
• Fig 35. Neurovascular devices market therapeutic applications outlook: Key takeaways
• Fig 36. Stroke market, 2018 - 2030 (USD Million)
• Fig 37. Cerebral artery stenosis market, 2018 - 2030 (USD Million)
• Fig 38. Cerebral aneurysm market, 2018 - 2030 (USD Million)
• Fig 39. Aneurysmal subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
• Fig 40. Others market, 2018 - 2030 (USD Million)
• Fig 41. Neurovascular devices market: Size movement analysis
• Fig 42. Neurovascular devices market size outlook: Key takeaways
• Fig 43. 0.027"market, 2018 - 2030 (USD Million)
• Fig 44. 0.021" market, 2018 - 2030 (USD Million)
• Fig 45. 0.021" market, 2018 - 2030 (USD Million)
• Fig 46. 0.071" market, 2018 - 2030 (USD Million)
• Fig 47. 0.046" market, 2018 - 2030 (USD Million)
• Fig 48. 0.019" market, 2018 - 2030 (USD Million)
• Fig 49. 0.013" market, 2018 - 2030 (USD Million)
• Fig 50. 0.058" market, 2018 - 2030 (USD Million)
• Fig 51. 0.068" market, 2018 - 2030 (USD Million)
• Fig 52. Others market, 2018 - 2030 (USD Million)
• Fig 53. Neurovascular devices market: End use movement analysis
• Fig 54. Neurovascular devices market end use outlook: Key takeaways
• Fig 55. Hospital market, 2018 - 2030 (USD Million)
• Fig 56. Specialty clinics market, 2018 - 2030 (USD Million)
• Fig 57. Others market, 2018 - 2030 (USD Million)
• Fig 58. Regional outlook, 2019 & 2027
• Fig 59. Regional market place: Key takeaways
• Fig 60. North America, SWOT, by PEST
• Fig 61. Europe, SWOT, by PEST
• Fig 62. Asia Pacific,, SWOT, by PEST
• Fig 63. Latin America, SWOT, by PEST
• Fig 64. Middle East and Africa,, SWOT, by PEST
• Fig 65. North America neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 66. U.S. neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 67. Canada neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 68. Europe neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 69. UK. neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 70. Germany neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 71. France neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 72. Italy neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 73. Spain neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 74. Norway neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 75. Denmark neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 76. Sweden neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 77. Asia Pacific neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 78. Japan neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 79. China neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 80. India neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 81. Australia neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 82. South Korea neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 83. Thailand neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 84. Latin America neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 85. Brazil neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 86. Mexico neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 87. Argentina neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 88. MEA neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 89. South Africa neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 90. Saudi Arabia neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 91. UAE neurovascular devices market, 2018 - 2030 (USD Million)
• Fig 92. Kuwait neurovascular devices market, 2018 - 2030 (USD Million)

Neurovascular Devices Market Growth & Trends:

The global neurovascular devices market size is expected to reach USD 4.53 billion by 2030, registering a CAGR of 6.01% from 2025 to 2030, according to a new report by Grand View Research, Inc. The rising prevalence of neurological illnesses such as stroke, brain aneurysm, and cerebral artery stenosis is driving growth of the neurovascular devices market. According to the World Stroke Organization (WSO), in 2022, there will be more than 12.2 million new strokes per year.

One in every four adults above the age of 25 will suffer a stroke throughout their lifetime. In addition, nearly 7.6 million new ischemic strokes occur each year. Around 62.0% of all incident strokes worldwide are ischemic strokes, with more than 1.2 million new subarachnoid hemorrhages occurring each year. As a result, the figures show that there is a significant demand for the neurovascular devices, which is driving neurovascular device market expansion.

The rising prevalence of brain aneurysms in both developed and developing countries is driving the introduction of technologically advanced products to the market. Some significant therapeutic techniques for an intracranial aneurysm include surgical clipping, endovascular coiling, and flow diverters. Market participants are constantly working to introduce technologically advanced products to the market.

For instance, in September 2021, Medtronic plc. announced the CE Mark clearance of its radial artery access portfolio, which comprises the Rist 079 Access Radial Guide Catheter and the Access Rist Radial Selective Catheter. Furthermore, in March 2022, Micro Port Scientific Company announced that its Hyper flex Balloon Catheter has received registration approval from the Japan Pharmaceuticals and Medical Devices Agency (PMDA).

Reduced postoperative discomfort and faster recovery are the factors expanding use of the minimally invasive operations and fueling R&D in this field. Endovascular coiling is a minimally invasive surgery that is frequently suggested by the clinicians for the treatment of cerebral aneurysms. Hydro Coils (MicroVention, Tustin, California, USA) have permitted the treatment of more complex aneurysmal structures with reduced recurrence rates as compared to bare-platinum coils. As a result, increased demand for the minimally invasive procedures is supporting neurovascular device market expansion.

Neurovascular Devices Market Report Highlights:

• Cerebral embolization and aneurysm coiling devices held the largest market share of around 36.02% in 2024. Coil embolization is a minimally invasive procedure for the treatment of aneurysms, wherein, the material closes the sac and reduces the risk of bleeding.
• Stroke held the largest market share of around 56.86% in 2024, owing to the factors such as increasing prevalence of hypertension, stroke, and other neurological disorders.
• 0.021" held the largest market share of around 27.08% in 2024. Segment growth can be attributed to various advantages provided by the 0.021" devices, along with various product launches and product approvals.
• Hospitals held the largest market share of around 70.79% in 2024. The growth of this segment can be attributed primarily to the increasing patient pool suffering from neurovascular disorders, such as ischemic & hemorrhagic stroke, brain aneurysm, Traumatic brain injury (TBI), and Arteriovenous Malformation (AVM).
• North America neurovascular devices dominated the market with a share of 27.62% in 2024 owing to the presence of key manufacturers such as Penumbra, Inc., Stryker Corporation, Johnson & Johnson, and Merit medical systems, Inc. in the region.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Device
  • 1.2.2. Therapeutic Applications
  • 1.2.3. Size
  • 1.2.4. End Use
  • 1.2.5. Regional Scope
  • 1.2.6. Estimates and forecasts timeline
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased database
  • 1.4.2. GVR's internal database
  • 1.4.3. Secondary sources
  • 1.4.4. Primary research
  • 1.4.5. Details of primary research
• 1.5. Information or Data Analysis
  • 1.5.1. Data analysis models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Commodity flow analysis (Model 1)
  • 1.7.2. Approach 1: Commodity flow approach
  • 1.7.3. Volume price analysis (Model 2)
  • 1.7.4. Approach 2: Volume price analysis
• 1.8. List of Secondary Sources
• 1.9. List of Primary Sources
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Regional outlook
• 2.4. Competitive Insights

Chapter 3. Neurovascular Devices Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence of Neurovascular Diseases
    • 3.2.1.2. Technological Advancements In Neurovascular Devices
    • 3.2.1.3. Rising Number of Awareness Initiatives
    • 3.2.1.4. Increasing Demand For Minimally Invasive Procedures
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Product Recalls
    • 3.2.2.2. High Treatment Cost Associated With Neurovascular Disorders
• 3.3. Neurovascular Devices Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. Neurovascular Devices Market: Segment Analysis, By Device, 2018 - 2030 (USD Million and Volume Unit)

• 4.1. Definition and Scope
• 4.2. Device Market Share Analysis, 2024 & 2030
• 4.3. Global Neurovascular Devices Market, by Device, 2018 to 2030
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 4.4.1. Cerebral Embolization and Aneurysm coiling devices
    • 4.4.1.1. Cerebral embolization and aneurysm coiling devices market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.1.2. Embolic coils
      • 4.4.1.2.1. Embolic coils market, 2018 - 2030 (USD Million)
    • 4.4.1.3. Flow diverters
      • 4.4.1.3.1. Flow diverters market, 2018 - 2030 (USD Million)
    • 4.4.1.4. Liquid embolic agents
      • 4.4.1.4.1. Liquid embolic agents market, 2018 - 2030 (USD Million)
  • 4.4.2. Cerebral angioplasty and stenting sytems
    • 4.4.2.1. Cerebral angioplasty and stenting sytems market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.2.2. Carotid Artery Stents
      • 4.4.2.2.1. Carotid artery stents market, 2018 - 2030 (USD Million)
    • 4.4.2.3. Embolic Protection Devices
      • 4.4.2.3.1. Embolic protection systems devices market, 2018 - 2030 (USD Million)
  • 4.4.3. Neurothrombectomy devices
    • 4.4.3.1. Neurothrombectomy devices market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.3.2. Clot Retrieval Devices
      • 4.4.3.2.1. Clot retrieval devices market, 2018 - 2030 (USD Million)
    • 4.4.3.3. Suction Devices
      • 4.4.3.3.1. Suction devices market, 2018 - 2030 (USD Million)
    • 4.4.3.4. Vascular Snares
      • 4.4.3.4.1. Vascular snares market, 2018 - 2030 (USD Million)
  • 4.4.4. Support devices
    • 4.4.4.1. Support devices market, 2018 - 2030 (USD Million and Volume Unit)
    • 4.4.4.2. Micro Catheters
      • 4.4.4.2.1. Micro catheters market, 2018 - 2030 (USD Million)
    • 4.4.4.3. Micro Guidewires
      • 4.4.4.3.1. Micro guidewires market, 2018 - 2030 (USD Million)
  • 4.4.5. Trans Radial Access Devices
    • 4.4.5.1. Trans radial access devices market, 2018 - 2030 (USD Million and Volume Unit)

Chapter 5. Neurovascular Devices Market: Segment Analysis, By Therapeutic Applications, 2018 - 2030 (USD Million)

• 5.1. Definition and Scope
• 5.2. Therapeutic Applications Market Share Analysis, 2024 & 2030
• 5.3. Global Neurovascular Devices Market, by Therapeutic Applications, 2018 to 2030
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 5.4.1. Stroke
    • 5.4.1.1. Stroke market, 2018 - 2030 (USD Million)
  • 5.4.2. Cerebral artery stenosis
    • 5.4.2.1. Cerebral artery stenosis market, 2018 - 2030 (USD Million)
  • 5.4.3. Cerebral aneurysm
    • 5.4.3.1. Cerebral aneurysm market, 2018 - 2030 (USD Million)
    • 5.4.3.2. Aneurysmal Subarachnoid Hemorrhage
      • 5.4.3.2.1. Aneurysmal subarachnoid hemorrhage market, 2018 - 2030 (USD Million)
    • 5.4.3.3. Others
      • 5.4.3.3.1. Others market, 2018 - 2030 (USD Million)
  • 5.4.4. Others
    • 5.4.4.1. Others market, 2018 - 2030 (USD Million)

Chapter 6. Neurovascular Devices Market: Segment Analysis, By Size, 2018 - 2030 (USD Million)

• 6.1. Definition and Scope
• 6.2. Size Market Share Analysis, 2024 & 2030
• 6.3. Global Neurovascular Devices Market, by Size, 2018 to 2030
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 6.4.1. 0.027"
    • 6.4.1.1. 0.027" market, 2018 - 2030 (USD Million)
  • 6.4.2. 0.021"
    • 6.4.2.1. 0.021" market, 2018 - 2030 (USD Million)
  • 6.4.3. 0.071"
    • 6.4.3.1. 0.071" market, 2018 - 2030 (USD Million)
  • 6.4.4. 0.017"
    • 6.4.4.1. 0.017" market, 2018 - 2030 (USD Million)
  • 6.4.5. 0.019"
    • 6.4.5.1. 0.019" market, 2018 - 2030 (USD Million)
  • 6.4.6. 0.013"
    • 6.4.6.1. 0.013" market, 2018 - 2030 (USD Million)
  • 6.4.7. 0.058"
    • 6.4.7.1. 0.058" market, 2018 - 2030 (USD Million)
  • 6.4.8. 0.068"
    • 6.4.8.1. 0.068" market, 2018 - 2030 (USD Million)
  • 6.4.9. Others
    • 6.4.9.1. Others market, 2018 - 2030 (USD Million)

Chapter 7. Neurovascular Devices Market: Segment Analysis, By End Use, 2018 - 2030 (USD Million)

• 7.1. Definition and Scope
• 7.2. End Use Market Share Analysis, 2024 & 2030
• 7.3. Global Neurovascular Devices Market, by End Use, 2018 to 2030
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030
  • 7.4.1. Hospital
    • 7.4.1.1. Hospital market, 2018 - 2030 (USD Million)
  • 7.4.2. Specialty clinics
    • 7.4.2.1. Specialty clinics market, 2018 - 2030 (USD Million)
  • 7.4.3. Others
    • 7.4.3.1. Others market, 2018 - 2030 (USD Million)

Chapter 8. Neurovascular Devices Market: Regional Estimates & Trend Analysis

• 8.1. Regional Dashboard
• 8.2. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
• 8.3. North America
  • 8.3.1. U.S.
    • 8.3.1.1. Key country dynamics
    • 8.3.1.2. Regulatory framework/ reimbursement structure
    • 8.3.1.3. Competitive scenario
    • 8.3.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.3.2. Canada
    • 8.3.2.1. Key country dynamics
    • 8.3.2.2. Regulatory framework/ reimbursement structure
    • 8.3.2.3. Competitive scenario
    • 8.3.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
• 8.4. Europe
  • 8.4.1. UK
    • 8.4.1.1. Key country dynamics
    • 8.4.1.2. Regulatory framework/ reimbursement structure
    • 8.4.1.3. Competitive scenario
    • 8.4.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.2. Germany
    • 8.4.2.1. Key country dynamics
    • 8.4.2.2. Regulatory framework/ reimbursement structure
    • 8.4.2.3. Competitive scenario
    • 8.4.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.3. France
    • 8.4.3.1. Key country dynamics
    • 8.4.3.2. Regulatory framework/ reimbursement structure
    • 8.4.3.3. Competitive scenario
    • 8.4.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.4. Italy
    • 8.4.4.1. Key country dynamics
    • 8.4.4.2. Regulatory framework/ reimbursement structure
    • 8.4.4.3. Competitive scenario
    • 8.4.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.5. Spain
    • 8.4.5.1. Key country dynamics
    • 8.4.5.2. Regulatory framework/ reimbursement structure
    • 8.4.5.3. Competitive scenario
    • 8.4.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.6. Norway
    • 8.4.6.1. Key country dynamics
    • 8.4.6.2. Regulatory framework/ reimbursement structure
    • 8.4.6.3. Competitive scenario
    • 8.4.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.7. Sweden
    • 8.4.7.1. Key country dynamics
    • 8.4.7.2. Regulatory framework/ reimbursement structure
    • 8.4.7.3. Competitive scenario
    • 8.4.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.4.8. Denmark
    • 8.4.8.1. Key country dynamics
    • 8.4.8.2. Regulatory framework/ reimbursement structure
    • 8.4.8.3. Competitive scenario
    • 8.4.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
• 8.5. Asia Pacific
  • 8.5.1. Japan
    • 8.5.1.1. Key country dynamics
    • 8.5.1.2. Regulatory framework/ reimbursement structure
    • 8.5.1.3. Competitive scenario
    • 8.5.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.2. China
    • 8.5.2.1. Key country dynamics
    • 8.5.2.2. Regulatory framework/ reimbursement structure
    • 8.5.2.3. Competitive scenario
    • 8.5.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.3. India
    • 8.5.3.1. Key country dynamics
    • 8.5.3.2. Regulatory framework/ reimbursement structure
    • 8.5.3.3. Competitive scenario
    • 8.5.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.4. Australia
    • 8.5.4.1. Key country dynamics
    • 8.5.4.2. Regulatory framework/ reimbursement structure
    • 8.5.4.3. Competitive scenario
    • 8.5.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.5. South Korea
    • 8.5.5.1. Key country dynamics
    • 8.5.5.2. Regulatory framework/ reimbursement structure
    • 8.5.5.3. Competitive scenario
    • 8.5.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.5.6. Thailand
    • 8.5.6.1. Key country dynamics
    • 8.5.6.2. Regulatory framework/ reimbursement structure
    • 8.5.6.3. Competitive scenario
    • 8.5.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
• 8.6. Latin America
  • 8.6.1. Brazil
    • 8.6.1.1. Key country dynamics
    • 8.6.1.2. Regulatory framework/ reimbursement structure
    • 8.6.1.3. Competitive scenario
    • 8.6.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.2. Argentina
    • 8.6.2.1. Key country dynamics
    • 8.6.2.2. Regulatory framework/ reimbursement structure
    • 8.6.2.3. Competitive scenario
    • 8.6.2.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.6.3. Mexico
    • 8.6.3.1. Key country dynamics
    • 8.6.3.2. Regulatory framework/ reimbursement structure
    • 8.6.3.3. Competitive scenario
    • 8.6.3.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
• 8.7. MEA
  • 8.7.1. South Africa
    • 8.7.1.1. Key country dynamics
    • 8.7.1.2. Regulatory framework/ reimbursement structure
    • 8.7.1.3. Competitive scenario
    • 8.7.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.2. Saudi Arabia
    • 8.7.2.1. Key country dynamics
    • 8.7.2.2. Regulatory framework/ reimbursement structure
    • 8.7.2.3. Competitive scenario
    • 8.7.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.3. UAE
    • 8.7.3.1. Key country dynamics
    • 8.7.3.2. Regulatory framework/ reimbursement structure
    • 8.7.3.3. Competitive scenario
    • 8.7.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
  • 8.7.4. Kuwait
    • 8.7.4.1. Key country dynamics
    • 8.7.4.2. Regulatory framework/ reimbursement structure
    • 8.7.4.3. Competitive scenario
    • 8.7.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Competitive Landscape

• 9.1. Market Participant Categorization
• 9.2. Recent Developments & Impact Analysis by Key Market Participants
• 9.3. Company Market Share Analysis, 2024
• 9.4. Key Company Profiles
  • 9.4.1. Medtronic
    • 9.4.1.1. Company overview
    • 9.4.1.2. Financial performance
    • 9.4.1.3. Product benchmarking
    • 9.4.1.4. Strategic initiatives
  • 9.4.2. Stryker Corporation
    • 9.4.2.1. Company overview
    • 9.4.2.2. Financial performance
    • 9.4.2.3. Product benchmarking
    • 9.4.2.4. Strategic initiatives
  • 9.4.3. Terumo Corporation
    • 9.4.3.1. Company overview
    • 9.4.3.2. Financial performance
    • 9.4.3.3. Product benchmarking
    • 9.4.3.4. Strategic initiatives
  • 9.4.4. Penumbra, Inc.
    • 9.4.4.1. Company overview
    • 9.4.4.2. Financial performance
    • 9.4.4.3. Product benchmarking
    • 9.4.4.4. Strategic initiatives
  • 9.4.5. Johnson & Johnson Services, Inc.
    • 9.4.5.1. Company overview
    • 9.4.5.2. Financial performance
    • 9.4.5.3. Product benchmarking
    • 9.4.5.4. Strategic initiatives
  • 9.4.6. Integra LifeSciences Corporation
    • 9.4.6.1. Company overview
    • 9.4.6.2. Financial performance
    • 9.4.6.3. Product benchmarking
    • 9.4.6.4. Strategic initiatives
  • 9.4.7. Acandis GmbH
    • 9.4.7.1. Company overview
    • 9.4.7.2. Financial performance
    • 9.4.7.3. Product benchmarking
    • 9.4.7.4. Strategic initiatives
  • 9.4.8. Spiegelberg GmbH & Co. KG
    • 9.4.8.1. Company overview
    • 9.4.8.2. Financial performance
    • 9.4.8.3. Product benchmarking
    • 9.4.8.4. Strategic initiatives
  • 9.4.9. MicroPort Scientific Corporation
    • 9.4.9.1. Company overview
    • 9.4.9.2. Financial performance
    • 9.4.9.3. Product benchmarking
    • 9.4.9.4. Strategic initiatives
  • 9.4.10. ZYLOX-TONBRIDGE MEDICAL TECHNOLOGY CO., LTD.
    • 9.4.10.1. Company overview
    • 9.4.10.2. Financial performance
    • 9.4.10.3. Product benchmarking
    • 9.4.10.4. Strategic initiatives